Vaccinex (VCNX) Tops Q1 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts VCNX Hot Sheet
Join SI Premium – FREE
Vaccinex (NASDAQ: VCNX) reported Q1 EPS of ($0.10), $0.20 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $550 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Vaccinex (VCNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox gains on strong earnings and revenue beat
- Fox Corporation (FOXA) Tops Q1 EPS by 48c
- Hartford Financial Services (HIG) PT Lowered to $136 at Cantor Fitzgerald
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
